Total Payments
$1,223
2023 Payments
$78.62
Companies
9
Transactions
20
Medicare Patients
2,744
Medicare Billing
$338,395
Payment Breakdown by Category
Food & Beverage$755.49 (61.7%)
Travel$468.00 (38.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $755.49 | 19 | 61.7% |
| Travel and Lodging | $468.00 | 1 | 38.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $468.00 | 1 | $0 (2018) |
| AstraZeneca Pharmaceuticals LP | $237.59 | 2 | $0 (2019) |
| Novo Nordisk Inc | $216.20 | 3 | $0 (2018) |
| Teva Pharmaceuticals USA, Inc. | $112.08 | 1 | $0 (2019) |
| Sunovion Pharmaceuticals Inc. | $77.67 | 7 | $0 (2018) |
| GlaxoSmithKline, LLC. | $64.21 | 3 | $0 (2023) |
| Pharmacyclics LLC, an AbbVie Company | $18.81 | 1 | $0 (2022) |
| Merck Sharp & Dohme Corporation | $14.52 | 1 | $0 (2018) |
| IDORSIA PHARMACEUTICALS US INC | $14.41 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $78.62 | 4 | GlaxoSmithKline, LLC. ($64.21) |
| 2022 | $18.81 | 1 | Pharmacyclics LLC, an AbbVie Company ($18.81) |
| 2019 | $227.88 | 2 | AstraZeneca Pharmaceuticals LP ($115.80) |
| 2018 | $777.00 | 11 | Novartis Pharmaceuticals Corporation ($468.00) |
| 2017 | $121.18 | 2 | Novo Nordisk Inc ($121.18) |
All Payment Transactions
20 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/03/2023 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $14.41 | General |
| Category: INSOMNIA | ||||||
| 09/12/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug), BEXSERO, SHINGRIX | Food and Beverage | In-kind items and services | $18.37 | General |
| Category: RESPIRATORY | ||||||
| 07/11/2023 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $19.29 | General |
| Category: VACCINES | ||||||
| 04/04/2023 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $26.55 | General |
| Category: VACCINES | ||||||
| 07/20/2022 | Pharmacyclics LLC, an AbbVie Company | IMBRUVICA (Drug) | Food and Beverage | In-kind items and services | $18.81 | General |
| Category: ONCOLOGY | ||||||
| 09/12/2019 | Teva Pharmaceuticals USA, Inc. | AJOVY (Drug) | Food and Beverage | In-kind items and services | $112.08 | General |
| Category: Central Nervous System | ||||||
| 02/26/2019 | AstraZeneca Pharmaceuticals LP | FASENRA (Drug) | Food and Beverage | In-kind items and services | $115.80 | General |
| Category: Respiratory | ||||||
| 11/06/2018 | Merck Sharp & Dohme Corporation | NEXPLANON (Drug) | Food and Beverage | In-kind items and services | $14.52 | General |
| Category: WOMENS HEALTH | ||||||
| 06/26/2018 | Sunovion Pharmaceuticals Inc. | Utibron (Drug), Seebri, Lonhala Magnair | Food and Beverage | In-kind items and services | $12.61 | General |
| Category: Respiratory | ||||||
| 06/06/2018 | Sunovion Pharmaceuticals Inc. | LONHALA MAGNAIR (Drug) | Food and Beverage | In-kind items and services | $16.17 | General |
| Category: Respiratory | ||||||
| 05/14/2018 | Sunovion Pharmaceuticals Inc. | LONHALA MAGNAIR (Drug) | Food and Beverage | In-kind items and services | $15.76 | General |
| Category: Respiratory | ||||||
| 05/14/2018 | Sunovion Pharmaceuticals Inc. | LONHALA MAGNAIR (Drug) | Food and Beverage | In-kind items and services | $1.14 | General |
| Category: Respiratory | ||||||
| 05/08/2018 | AstraZeneca Pharmaceuticals LP | BEVESPI AEROSPHERE (Drug) | Food and Beverage | In-kind items and services | $121.79 | General |
| Category: Respiratory | ||||||
| 04/17/2018 | Sunovion Pharmaceuticals Inc. | BROVANA (Drug) | Food and Beverage | In-kind items and services | $16.06 | General |
| Category: RESPIRATORY | ||||||
| 03/13/2018 | Sunovion Pharmaceuticals Inc. | BROVANA (Drug) | Food and Beverage | In-kind items and services | $14.93 | General |
| Category: RESPIRATORY | ||||||
| 03/13/2018 | Sunovion Pharmaceuticals Inc. | BROVANA (Drug) | Food and Beverage | In-kind items and services | $1.00 | General |
| Category: RESPIRATORY | ||||||
| 02/13/2018 | Novo Nordisk Inc | Tresiba (Drug) | Food and Beverage | In-kind items and services | $95.02 | General |
| Category: Diabetes | ||||||
| 01/17/2018 | Novartis Pharmaceuticals Corporation | — | Travel and Lodging | In-kind items and services | $468.00 | General |
| 09/29/2017 | Novo Nordisk Inc | Victoza (Drug), Tresiba | Food and Beverage | In-kind items and services | $18.56 | General |
| Category: Diabetes | ||||||
| 02/28/2017 | Novo Nordisk Inc | Tresiba (Drug) | Food and Beverage | In-kind items and services | $102.62 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 802 | 2,270 | $388,381 | $111,908 |
| 2022 | 12 | 688 | 2,161 | $373,535 | $103,318 |
| 2021 | 12 | 596 | 860 | $231,625 | $67,468 |
| 2020 | 10 | 658 | 907 | $186,665 | $55,701 |
Total Patients
2,744
Total Services
6,198
Medicare Billing
$338,395
Procedure Codes
47
All Medicare Procedures & Services
47 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 221 | 391 | $136,967 | $38,268 | 27.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 199 | 293 | $72,796 | $20,422 | 28.1% |
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 15 | 1,140 | $82,328 | $19,800 | 24.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 119 | 119 | $42,697 | $16,339 | 38.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 46 | 50 | $24,564 | $6,742 | 27.4% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 48 | 48 | $9,180 | $3,453 | 37.6% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 11 | 11 | $9,462 | $3,078 | 32.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 54 | 55 | $2,475 | $1,811 | 73.2% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 11 | 14 | $4,253 | $803.72 | 18.9% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 16 | 16 | $720.00 | $526.88 | 73.2% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 22 | 36 | $1,658 | $431.20 | 26.0% |
| 93005 | Routine electrocardiogram (ecg) using at least 12 leads with tracing | Office | 2023 | 29 | 32 | $788.48 | $177.74 | 22.5% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 11 | 65 | $493.35 | $55.24 | 11.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 242 | 431 | $150,993 | $41,021 | 27.2% |
| J0897 | Injection, denosumab, 1 mg | Office | 2022 | 13 | 1,200 | $91,476 | $20,743 | 22.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 152 | 204 | $50,665 | $13,351 | 26.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 59 | 59 | $21,165 | $8,367 | 39.5% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 27 | 27 | $23,225 | $7,536 | 32.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 37 | 46 | $22,589 | $6,554 | 29.0% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 24 | 24 | $4,574 | $1,645 | 36.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 39 | 41 | $1,845 | $1,339 | 72.6% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 35 | 35 | $1,575 | $1,149 | 73.0% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 11 | 12 | $2,293 | $831.54 | 36.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 17 | 48 | $2,293 | $604.42 | 26.4% |
| 93005 | Routine electrocardiogram (ecg) using at least 12 leads with tracing | Office | 2022 | 32 | 34 | $841.66 | $177.65 | 21.1% |
About Dr. Heather Doherty, M.D
Dr. Heather Doherty, M.D is a Geriatric Medicine healthcare provider based in La Jolla, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/04/2006. The National Provider Identifier (NPI) number assigned to this provider is 1255319802.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Heather Doherty, M.D has received a total of $1,223 in payments from pharmaceutical and medical device companies, with $78.62 received in 2023. These payments were reported across 20 transactions from 9 companies. The most common payment nature is "Food and Beverage" ($755.49).
As a Medicare-enrolled provider, Doherty has provided services to 2,744 Medicare beneficiaries, totaling 6,198 services with total Medicare billing of $338,395. Data is available for 4 years (2020–2023), covering 47 distinct procedure/service records.
Ad
Practice Information
- Specialty Geriatric Medicine
- Location La Jolla, CA
- Active Since 01/04/2006
- Last Updated 01/26/2011
- Taxonomy Code 207RG0300X
- Entity Type Individual
- NPI Number 1255319802
Products in Payments
- Tresiba (Drug) $197.64
- BEVESPI AEROSPHERE (Drug) $121.79
- FASENRA (Drug) $115.80
- AJOVY (Drug) $112.08
- SHINGRIX (Biological) $45.84
- LONHALA MAGNAIR (Drug) $33.07
- BROVANA (Drug) $31.99
- IMBRUVICA (Drug) $18.81
- Victoza (Drug) $18.56
- AREXVY (Drug) $18.37
- NEXPLANON (Drug) $14.52
- QUVIVIQ (Drug) $14.41
- Utibron (Drug) $12.61
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Geriatric Medicine Doctors in La Jolla
Francis Allinson, Md, MD
Geriatric Medicine — Payments: $2,158
Geriatric Medicine $2,158
Carly Waldman, Md, MD
Geriatric Medicine — Payments: $1,405
Geriatric Medicine $1,405
Adil Abbasi, M.d, M.D
Geriatric Medicine — Payments: $894.31
Geriatric Medicine $894.31
Dr. Joann Stewart, M.d, M.D
Geriatric Medicine — Payments: $565.89
Geriatric Medicine $565.89
Dr. Dennis Ehrlich, Md, MD
Geriatric Medicine — Payments: $288.68
Geriatric Medicine $288.68
Sara Davies, Md, MD
Geriatric Medicine — Payments: $242.53
Geriatric Medicine $242.53